Genmab — April 2023
-
Nå, så kommer der ikke bud på Genmab inden for nærmeste fremtid. Heller ikke en voldgiftsafgørelse som de har fået et hint om …
-
New Desensitization Strategy: Daratumumab for Highly Sensitized Pediatric Heart Transplant Candidate https://www.sciencedirect.com/science/article/abs/pii/S105324982301361X
-
Use of Daratumumab in Antibody Mediated Rejection in a Heart Transplant Recipient
https://www.jhltonline.org/article/S1053-2498(23)01274-3/fulltext -
We reported that 4 patients with refractory acquired hemophilia A were treated with daratumumab.. All 4 patients achieved varying degrees of remission after daratumumab treatment.. Daratumumab provides a new option for the treatment of refractory acquired hemophilia with good efficacy and safety
. -
-
Det har åbenbart været kendt længe. For eksempel her: https://onlinelibrary.wiley.com/doi/10.1111/hae.14118
-
-
Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA
(teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-announces-positive-topline-data
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind